Particularly well-placed to advise on cross-border mandates, Bird & Bird‘s healthcare and life sciences team advises large, multinational clients in the sector on a range of matters related to contentious and non-contentious IP, data protection and patent disputes. Co-head Ann Henry is particularly well-versed in complex litigation, with experience handling large patent disputes before the Commercial Court. Michael Finn, who also leads the team, is noted for his regulatory and product liability work, as well as his IP litigation practice. Another key contact for healthcare and life sciences clients is Deirdre Kilroy.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Lawyer & team quality
Client satisfaction: Billing & efficiency
Client satisfaction: Sector knowledge
Client satisfaction: NPS ®
Testimonials
Collated independently by Legal 500 research team.
- 'Ann Henry has particular experience in patent pharmaceuticals litigation.'
- 'Sarah McMullen is recommended for her accessibility and consistently razor-sharp advice.'
- 'Open and approachable, and professionally outstanding.'
- 'Ann Henry receives my highest recommendation. In my view, she is one of the leading advisers/lawyers in the market within IPR and Life Sciences. She is accessible, approachable, and highly skilled professionally. She is the go-to person when you need a truly capable lawyer in the IPR/Life Sciences field.'
Key clients
- Sandoz AG and Rowex Limited
- Merck KGaA
- Pharmeng
Work highlights
Acted for Sandoz AG and Rowex Limited in successfully invalidating patent EP (IE) 1 845 961 previously held by Bayer Intellectual Property GmbH with respect to the treatment of thromboembolic disorders with rivaroxaban.
Advising Merck KGaA in relation to a trade mark infringement, breach of contract and passing-off claim against Merck Sharp & Dohme LLC
Practice head
Ann Henry; Michael Finn
Other key lawyers
Deirdre Kilroy; Sarah McMullen